G Auclerc
Impact in
- Oncology top 5%
- Cutaneous Melanoma Detection and Management
- Cancer Treatment and Pharmacology
- HER2/EGFR in Cancer Research
- Cancer Research top 10%
- Breast Cancer Treatment Studies
Papers in
- Oncology 36
- Cancer Treatment and Pharmacology 19
- Cutaneous Melanoma Detection and Management 6
-
- Breast Cancer Treatment Studies 9
G Auclerc
54 papers receiving 870 citations
Peers
Comparison fields: 5 of 66
- Oncology 551
- Cancer Research 296
- Pathology and Forensic Medicine 278
- Hematology 134
- Genetics 82
Countries citing papers authored by G Auclerc
This map shows the geographic impact of G Auclerc's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by G Auclerc with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites G Auclerc more than expected).
Fields of papers citing papers by G Auclerc
This network shows the impact of papers produced by G Auclerc. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by G Auclerc. The network helps show where G Auclerc may publish in the future.
Co-authorship network
The 25 scholars most cited alongside G Auclerc, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2003 | 171 | |
| 2 | 2000 | 1 | |
| 3 | 1997 | 3 | |
| 4 | 1995 | 6 | |
| 5 | 1995 | 10 | |
| 6 | 1995 | 3 | |
| 7 | 1993 | 6 | |
| 8 | [Primary chemotherapy in the treatment of breast cancer]. | 1992 | 17 |
| 9 | 1992 | 2 | |
| 10 | 1991 | 13 | |
| 11 | 1990 | 193 | |
| 12 | 1988 | 62 | |
| 13 | Neoadjuvant chemotherapy of breast cancer. | 1986 | 6 |
| 14 | [Vegetating iododerma following lymphography]. | 1985 | 2 |
| 15 | Cancer du sein: chimiothérapie précédant le traitement loco-régional avec extension des indications du traitement conservateur. | 1984 | 3 |
| 16 | [Acute leukemias and solid tumors in the course of Hodgkin disease]. | 1983 | 3 |
| 17 | [Sites of relapse in Hodgkin's disease with bone marrow involvement treated by multiagent-chemotherapy (author's transl)]. | 1978 | 1 |
| 18 | [Chemotherapy of breast cancers]. | 1977 | 6 |
| 19 | [Polychemotherapy of Hodgkin's disease. Long-term results in 226 cases]. | 1977 | 0 |
| 20 | 1973 | 34 |
About G Auclerc
G Auclerc is a scholar working on Oncology, Cancer Research, Pathology and Forensic Medicine, Pulmonary and Respiratory Medicine and Genetics, having authored 56 papers that have together received 933 indexed citations. Recurring topics across this work include Cancer Treatment and Pharmacology (19 papers), Lymphoma Diagnosis and Treatment (11 papers), Breast Cancer Treatment Studies (9 papers), Lung Cancer Treatments and Mutations (8 papers), Cutaneous Melanoma Detection and Management (6 papers), Melanoma and MAPK Pathways (5 papers), Acute Lymphoblastic Leukemia research (5 papers) and Chronic Lymphocytic Leukemia Research (4 papers). The work is most often cited by research in Oncology (551 citations), Cancer Research (296 citations), Pathology and Forensic Medicine (278 citations), Hematology (134 citations) and Genetics (82 citations). G Auclerc has collaborated with scholars based in France, United States and Canada. Frequent co-authors include David Khayat, M Weil, Claude Soubrane, C Jacquillat, F Baillet, L Thill, Marise Weil, Pierre Banzet, C Jacquillat and Olivier Rixe. Their work appears in journals such as Cancer, European Journal of Cancer, Melanoma Research, Journal of Clinical Oncology and Recent results in cancer research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.